Vista Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2025 ,inter alia, to consider and approve 1. Unaudited financial results for the quarter ended 30.09.2025. 2. Limited Review Report for quarter ended 30.09.2025. 3. Any other business with the permission of the Chair.